ZEB2 positively regulated the proportion of CD133+ cancer stem-like cells in epithelial ovarian cancer cells and promote the tumorigenesis and peritoneal metastasis capacity of CD133+ cancer stem-like cells. Here, PROM1 is linked to ovarian carcinoma.